Cardinal Health, Inc.
NYSE:CAHMedical - Distribution
-$3.77 today
- Market cap
- $64.33B
- Beta
- 0.53
- P/E (TTM)
- 33.5
- EPS (TTM)
- $6.63
- Dividend yield
- 0.92%
Volume 1.35M
Average 2.11M
CAH Other Income / Expenses
Net non-operating gains and losses, such as investment results, currency effects, and one-off items.
Cardinal Health, Inc.NYSE: CAH
Other Income / Expenses · Q1 FY2027 · quarter ended Sep 2026
Other income / expenses remains negative
Q1 FY2027 other income / expenses was -$65M, compared with -$70M a year earlier. Trailing-twelve-month other income / expenses was -$434M.
Context
- Other income / expenses amounted to 0.2% of revenue in FY2026, unchanged from a year earlier.
- Other income / expenses grew in size in 2 of the last 3 fiscal years.
- FY2026 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly other income / expenses holds near -$65M or moves back toward the trailing-twelve-month quarterly average of -$108.5M.
Sources:Income StatementText generated from reported figures; not investment advice.
Other Income / Expenses history
USD · from the income statement
- Latest · FY2026
- (439M) USD
- Year-over-year change
- -152.3%
| Period | Period end | Other Income / Expenses | YoY change |
|---|---|---|---|
| FY2026 | 2026-06-30 | (439M) | -152.3% |
| FY2025 | 2025-06-30 | (174M) | -314.3% |
| FY2024 | 2024-06-30 | (42M) | +52.8% |
| FY2023 | 2023-06-30 | (89M) | +49.7% |
| FY2022 | 2022-06-30 | (177M) | — |
Other Income / Expenses vs competitors
How CAH compares with its peers on the latest reported figures
- CAH's LTM Sep 2026 other income / expenses of -$434M is the 3rd highest of the 4 companies compared; the peer median is -$216M.
- Its year-over-year change of -100.0% is the 3rd highest of 4, against a peer median of +11.1%.
- Other income / expenses amounts to 0.2% of revenue for CAH, versus a peer median of 0.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | -$196M | -188.3% | — | 0.0% | |
| LTM Jun 2026 | -$216M | +11.1% | — | 1.6% | |
| LTM Sep 2026 | -$434M | -100.0% | — | 0.2% | |
| LTM Jun 2026 | -$729.59M | +18.5% | — | 0.2% | |
| Peer median (excluding CAH) | -$216M | +11.1% | — | 0.2% | |
Competitors are the stored peer set for CAH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 | FY2026 Jun 2026 |
|---|---|---|---|---|---|
| Revenue | 181.33B | 204.98B | 226.83B | 222.58B | 254.25B |
| Cost of Revenue | 174.84B | 198.11B | 219.41B | 214.41B | 244.47B |
| Gross Profit | 6.48B | 6.89B | 7.41B | 8.17B | 9.77B |
| Gross Margin | 3.6% | 3.4% | 3.3% | 3.7% | 3.8% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 4.51B | 4.8B | 5B | 5.38B | 6.13B |
| Operating Expenses | 7.09B | 6.12B | 6.17B | 5.89B | 7.16B |
| Depreciation & Amortization | 692M | 692M | 710M | 790M | 956M |
| EBITDA | 55M | 1.44B | 1.96B | 3.11B | 3.48B |
| EBITDA Margin | 0.0% | 0.7% | 0.9% | 1.4% | 1.4% |
| Operating Income | (607M) | 752M | 1.24B | 2.28B | 2.61B |
| Operating Margin | -0.3% | 0.4% | 0.5% | 1.0% | 1.0% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 147M | 84M | 51M | 215M | 348M |
| Other Income / Expenses | (177M) | (89M) | (42M) | (174M) | (439M) |
| Income Before Tax | (784M) | 663M | 1.2B | 2.1B | 2.17B |
| Pre-Tax Margin | -0.4% | 0.3% | 0.5% | 0.9% | 0.9% |
| Income Tax Expense | 153M | 332M | 348M | 532M | 469M |
| Net Income | (938M) | 330M | 852M | 1.56B | 1.71B |
| Net Margin | -0.5% | 0.2% | 0.4% | 0.7% | 0.7% |
| EPS (Basic) | (3.34) | 1.26 | 3.48 | 6.48 | 7.27 |
| EPS (Diluted) | (3.34) | 1.26 | 3.45 | 6.45 | 7.23 |
| Weighted Avg Shares | 279M | 261M | 245M | 241M | 236M |
| Weighted Avg Shares (Diluted) | 279M | 262M | 247M | 242M | 237M |
Cardinal Health, Inc.
NYSE:CAH
Intrinsic Alpha fair value
Locked
Current Price
$278.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.